Shares of Alembic Pharmaceuticals Ltd surged more than 2% on 28 July after the company announced securing final approval from the USFDA for Carbamazepine Extended-Release...
Under the futures and options (F&O) segment, one stock was banned from trade on Monday, 28 July, by the National Stock Exchange (NSE). The securities...